JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene

Title
JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene
Authors
Keywords
-
Journal
NEUROLOGY
Volume 83, Issue 8, Pages 727-732
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2014-07-19
DOI
10.1212/wnl.0000000000000713

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search